Last reviewed · How we verify

Er Zhi Wan combined with Si Wu Tang

Peking University Third Hospital · Phase 3 active Small molecule

Er Zhi Wan combined with Si Wu Tang is a Small molecule drug developed by Peking University Third Hospital. It is currently in Phase 3 development for Age-related macular degeneration or vision decline, Anemia or hematologic deficiency conditions. Also known as: conventional western medicine(Recombinant Human Follitropin Alfa for Injection、Fructose Injection、Tetyacycline Hydrochloride Capsules、Cetrorelix Acetate Powder for Injection ).

This traditional Chinese medicine combination nourishes blood and yin to address deficiency-related conditions, particularly those affecting vision and hematologic function.

This traditional Chinese medicine combination nourishes blood and yin to address deficiency-related conditions, particularly those affecting vision and hematologic function. Used for Age-related macular degeneration or vision decline, Anemia or hematologic deficiency conditions.

At a glance

Generic nameEr Zhi Wan combined with Si Wu Tang
Also known asconventional western medicine(Recombinant Human Follitropin Alfa for Injection、Fructose Injection、Tetyacycline Hydrochloride Capsules、Cetrorelix Acetate Powder for Injection )
SponsorPeking University Third Hospital
ModalitySmall molecule
Therapeutic areaOphthalmology / Hematology
PhasePhase 3

Mechanism of action

Er Zhi Wan (Two Immortals Decoction) traditionally tonifies liver and kidney yin, while Si Wu Tang (Four Substances Decoction) nourishes blood and invigorates circulation. The combination is used in Chinese medicine to address yin deficiency with blood stasis, commonly applied to age-related vision decline and hematologic disorders. The mechanism is based on traditional Chinese medicine theory rather than identified molecular targets.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Er Zhi Wan combined with Si Wu Tang

What is Er Zhi Wan combined with Si Wu Tang?

Er Zhi Wan combined with Si Wu Tang is a Small molecule drug developed by Peking University Third Hospital, indicated for Age-related macular degeneration or vision decline, Anemia or hematologic deficiency conditions.

How does Er Zhi Wan combined with Si Wu Tang work?

This traditional Chinese medicine combination nourishes blood and yin to address deficiency-related conditions, particularly those affecting vision and hematologic function.

What is Er Zhi Wan combined with Si Wu Tang used for?

Er Zhi Wan combined with Si Wu Tang is indicated for Age-related macular degeneration or vision decline, Anemia or hematologic deficiency conditions.

Who makes Er Zhi Wan combined with Si Wu Tang?

Er Zhi Wan combined with Si Wu Tang is developed by Peking University Third Hospital (see full Peking University Third Hospital pipeline at /company/peking-university-third-hospital).

Is Er Zhi Wan combined with Si Wu Tang also known as anything else?

Er Zhi Wan combined with Si Wu Tang is also known as conventional western medicine(Recombinant Human Follitropin Alfa for Injection、Fructose Injection、Tetyacycline Hydrochloride Capsules、Cetrorelix Acetate Powder for Injection ).

What development phase is Er Zhi Wan combined with Si Wu Tang in?

Er Zhi Wan combined with Si Wu Tang is in Phase 3.

What are the side effects of Er Zhi Wan combined with Si Wu Tang?

Common side effects of Er Zhi Wan combined with Si Wu Tang include Gastrointestinal upset, Allergic reaction to herbal components.

Related